![[PRC HOME]](images/hivribbon.gif) |
|
 |
 |
|
|
 |
 |
|
 |
 |
 |
| |
Multi-Center Network for Outcomes Research in HIV Pharmacotherapy
Antiviral Clinical Pharmacology Unit
Department of Pharmacy Practice
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
|
|
-
To establish a network of clinicians capable of
conducting multi-center research in HIV
Pharmacotherapeutics
-
Potential areas of investigation:
-
Pharmacokinetics - drug interactions
-
Outcomes Research - pharmacoepidemiology
-
Pharmacoeconomics - quality of life research
-
Adherence Research - adverse drug reactions
-
Validation of clinical tools
-
HIV Pharmacotherapy Website to be used for site
registration, data collection/storage, statistical
support, and dissemination of clinical information
-
Rigid data-entry criteria requires upfront work, but will
save time in long run
-
Site Registration/Survey:
-
Principle Investigator at each site
-
Summary of patient Demographics
-
Feasibility Information for Medical Record Access
-
Description of pharmacotherapy services
-
Site Registration and Approval
-
Review of study proposals
-
Review of publication of results to ensure lack of bias
in reports
-
Industry sponsorship of concept sheets will be
encouraged, although not required
-
unfunded projects will require volunteer time on the
part of Principle Investigator
-
Previous volunteer work will increase priority for
funded projects at a later date
-
Fiscal matters may be handled 2 ways:
-
Administered via the Network homebase (UB)
-
Administered via the Institution of a Registered
Principle Investigator
-
Indirect Cost for use of Network (~25%)
-
Compensation for medical record review and data input
into CRF will be standardized at a rate of $50-$100 per
chart
-
Prototype Project:
-
Cross-sensitivity between Amprenavir and
Trimethoprim-Sulfamethoxazole in HIV Patients (ACPU
121)
-
Create infra-structure of network and On-line Case Report
Form
-
Network available to pharmaceutical industry or other
investigators
-
Apply for peer-reviewed grant funding
-
Honoraria for Review Board members:
-
Database development:
-
16 hours of consultant time at $100/hour
-
Time spent training Network support staff to learn to
manage database
-
Total to initiate pilot phase:
-
Mark and Nancy met with Diane White (Microsoft Access
consultant) on 1/22/01
-
Established basic fields and tables for data to be used
in the project:
-
PI registration - used for all projects
-
Site registration- used for all projects
-
Include survey of scope of Rx practices in HIV
-
Subject registration - used for all projects
-
Protocol Case Report Form - specific projects
-
Created a nice "pull down"
table containing both generic and trade names for
medications:
-
Antiretrovirals
-
Other medications
-
Need to continue to specify all fields and criteria for
these fields in the CRF (Mark Shelton will prepare these
items)
-
Excellent example recently published of similar project
that "networked" three
sites
-
Bersoff-Matcha SJ, et al. Sex differences in
nevirapine rash. CID. 2001;32:124-9
-
plan to contact authors to see if they will share
their data collection form
-
Draft a letter to members of the research board:
-
outlining their responsibilities
-
Website questions:
-
how will the website interact with Access?
-
Direct interaction vs. download in textformat
-
what machine/platform is the website running on?
UNIX vs. Windows NT
-
Diane White indicates that the
"forms" for data entry
will need to be created within the website, but the
tables can be generated in Access
-
if all criteria and field characteristics are defined
in Access, it will be easier for the webmaster
-
At website 1/25/01 meeting, there was discussion re:
format for data-entry at sites:
-
data entered at sites into Access-based program
provided by Website and then emailed to website for
combining with other data
-
faster, sites would retain their own data
-
data entered at sites directly into the website:
-
slow speed, allows site access to their own data
-
Subject numbers remain an issue:
-
assignment, prevention of duplication
Back to TOP
|
 |
|
| |

|